Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression.
- DOI
- 10.1186/s12943-025-02444-1
- Published
- 2025 Oct 27
- Container
- Molecular cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-025-02444-1,
title = {Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression.},
author = {Füredi A and Tóth S and Hegedüs K and Szabó PT and Gaál A and Barta G and Naszályi LN and Kiss K and Bölcskei K and Szeltner Z and Bajtai E and Gombos B and Kiss D and Cserepes MT and Kiss A and Pokreisz P and Kenner L and Högler S and Magyar C and Cowles JD and Csiszar A and Tóvári J and Szüts D and Helyes Z and Varga Z and Mező G and Szakács G},
year = {2025},
journal = {Molecular cancer},
doi = {10.1186/s12943-025-02444-1},
url = {https://doi.org/10.1186/s12943-025-02444-1}
}RIS
TY - JOUR TI - Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression. AU - Füredi A AU - Tóth S AU - Hegedüs K AU - Szabó PT AU - Gaál A AU - Barta G AU - Naszályi LN AU - Kiss K AU - Bölcskei K AU - Szeltner Z AU - Bajtai E AU - Gombos B AU - Kiss D AU - Cserepes MT AU - Kiss A AU - Pokreisz P AU - Kenner L AU - Högler S AU - Magyar C AU - Cowles JD AU - Csiszar A AU - Tóvári J AU - Szüts D AU - Helyes Z AU - Varga Z AU - Mező G AU - Szakács G PY - 2025 JO - Molecular cancer DO - 10.1186/s12943-025-02444-1 UR - https://doi.org/10.1186/s12943-025-02444-1 ER -
APA
A, F., S, T., K, H., PT, S., A, G., G, B., LN, N., K, K., K, B., Z, S., E, B., B, G., D, K., MT, C., A, K., P, P., L, K., S, H., C, M., JD, C., A, C., J, T., D, S., Z, H., Z, V., G, M., & G, S. (2025). Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression.. Molecular cancer. https://doi.org/10.1186/s12943-025-02444-1
Source records
- pubmed · retrieved 2026-09-27T07:03:00.271Z